X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (14323) 14323
Publication (1715) 1715
Book Review (860) 860
Newsletter (757) 757
Book Chapter (51) 51
Conference Proceeding (33) 33
Newspaper Article (12) 12
Magazine Article (8) 8
Data Set (6) 6
Dissertation (4) 4
Trade Publication Article (4) 4
Paper (2) 2
Book / eBook (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
index medicus (12274) 12274
humans (9466) 9466
viremia (8670) 8670
female (5537) 5537
male (5350) 5350
adult (4123) 4123
animals (4007) 4007
infectious diseases (3702) 3702
immunology (3534) 3534
virology (3487) 3487
middle aged (3176) 3176
viral load (3119) 3119
infection (3008) 3008
viruses (2464) 2464
hiv (2434) 2434
viremia - virology (2331) 2331
infections (2124) 2124
aids/hiv (2002) 2002
hiv infections - virology (1983) 1983
health aspects (1971) 1971
rna, viral - blood (1922) 1922
virus diseases (1903) 1903
microbiology (1884) 1884
hiv infections - drug therapy (1830) 1830
research (1683) 1683
hiv infections - immunology (1657) 1657
abridged index medicus (1641) 1641
viremia - immunology (1549) 1549
polymerase chain reaction (1465) 1465
rna (1371) 1371
aged (1341) 1341
aids (1326) 1326
disease (1303) 1303
adolescent (1302) 1302
transplantation (1140) 1140
cd4 lymphocyte count (1139) 1139
human immunodeficiency virus--hiv (1138) 1138
hiv infection (1131) 1131
analysis (1124) 1124
risk factors (1106) 1106
antibodies, viral - blood (1083) 1083
antiretroviral therapy (1078) 1078
replication (1063) 1063
time factors (1060) 1060
viremia - drug therapy (1041) 1041
antibodies (1040) 1040
viremia - diagnosis (1018) 1018
hiv-1 - genetics (985) 985
anti-hiv agents - therapeutic use (967) 967
veterinary sciences (955) 955
dna, viral - blood (930) 930
mice (918) 918
dna (907) 907
antiviral agents - therapeutic use (903) 903
antiviral agents (901) 901
human-immunodeficiency-virus (895) 895
prevalence (890) 890
hiv-1 - immunology (887) 887
genotype (882) 882
child (873) 873
disease progression (867) 867
hepacivirus - genetics (827) 827
lymphocytes (819) 819
virus replication (817) 817
treatment outcome (807) 807
molecular sequence data (803) 803
therapy (798) 798
gastroenterology & hepatology (790) 790
hiv-1 (774) 774
prospective studies (774) 774
drug therapy (773) 773
viremia - veterinary (770) 770
medical research (763) 763
blood (754) 754
antiretroviral therapy, highly active (748) 748
vaccines (747) 747
transmission (746) 746
vaccination (733) 733
hiv-1 - isolation & purification (728) 728
research article (727) 727
young adult (727) 727
care and treatment (718) 718
multidisciplinary sciences (714) 714
human immunodeficiency virus (712) 712
virus (710) 710
highly active antiretroviral therapy (705) 705
diagnosis (694) 694
hematology (691) 691
hepatitis c (690) 690
cd4-positive t-lymphocytes - immunology (682) 682
sensitivity and specificity (677) 677
cd8-positive t-lymphocytes - immunology (675) 675
t cells (669) 669
measurement (663) 663
cohort studies (662) 662
active antiretroviral therapy (659) 659
child, preschool (658) 658
hepatitis (652) 652
hepatitis c virus (652) 652
retrospective studies (649) 649
more...
Library Location Library Location
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (14515) 14515
Spanish (170) 170
French (155) 155
Russian (88) 88
German (85) 85
Chinese (38) 38
Italian (31) 31
Japanese (14) 14
Polish (12) 12
Portuguese (12) 12
Czech (9) 9
Korean (9) 9
Turkish (3) 3
Azerbaijani (2) 2
Hungarian (2) 2
Romanian (2) 2
Bulgarian (1) 1
Croatian (1) 1
Danish (1) 1
Serbian (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


PLoS ONE, ISSN 1932-6203, 02/2013, Volume 8, Issue 2, pp. e57835 - e57835
Backgrounds: With 10% of the general population aged 15-59 years chronically infected with hepatitis C virus (HCV), Egypt is the country with the highest HCV... 
TRANSMISSION | RISK-FACTORS | VIRUS | NEEDLESTICK INJURIES | MULTIDISCIPLINARY SCIENCES | CELLULAR IMMUNE-RESPONSES | HCV-VIREMIA | BLOOD EXPOSURES | INFECTION | ABSENCE | OCCUPATIONAL-EXPOSURE | Humans | Male | Egypt - epidemiology | Health Personnel - statistics & numerical data | Young Adult | Hepatitis C - blood | Hepatitis C - epidemiology | Viremia - epidemiology | Adult | Female | Viremia - blood | Viremia - transmission | Hepatitis C - transmission | Occupational Exposure - statistics & numerical data | Medical personnel | Infection | Medical research | RNA | Viremia | Workers | Medicine, Experimental | Hepatitis C virus | Health aspects | Health care | Laboratories | Standardization | Antibodies | Viruses | Risk | Infections | Occupational exposure | Epidemiology | Blood | Developing countries--LDCs | Hepatitis | Hepatology | Age | Health risks | Exposure | Ribonucleic acid--RNA | Patients | Seroconversion | Disease control | Medicine | Studies | Screening | Hospitals | Hepatitis C | Needlestick injuries | Index Medicus | Hepatitis C/epidemiology | Hepatitis C/blood | Hepatitis C/transmission | Viremia/transmission | Life Sciences | Viremia/blood | Immunology | Health Personnel/statistics & numerical data | Egypt/epidemiology | Viremia/epidemiology | Occupational Exposure/statistics & numerical data | Developing countries | Ribonucleic acid | LDCs
Journal Article
The Journal of Infectious Diseases, ISSN 0022-1899, 8/2012, Volume 206, Issue 3, pp. 389 - 398
Journal Article
Nature, ISSN 0028-0836, 09/2018, Volume 561, Issue 7724, pp. 479 - 484
Individuals infected with HIV-1 require lifelong antiretroviral therapy, because interruption of treatment leads to rapid rebound viraemia. Here we report on a... 
SHIV INFECTION | PRIMARY HIV-INFECTION | RESERVOIR | DURABLE CONTROL | BROADLY NEUTRALIZING ANTIBODIES | MULTIDISCIPLINARY SCIENCES | PASSIVE TRANSFER | IN-VIVO | TREATMENT INTERRUPTION | T-CELLS | HUMANIZED MICE | Antibodies, Neutralizing - administration & dosage | Humans | Middle Aged | Antibodies, Monoclonal - adverse effects | Drug Resistance, Viral | Antibodies, Monoclonal - therapeutic use | Male | Phylogeny | Anti-HIV Agents - administration & dosage | Young Adult | HIV Infections - immunology | Antibodies, Neutralizing - immunology | HIV Antibodies - adverse effects | HIV Antibodies - immunology | HIV-1 - isolation & purification | Antibodies, Neutralizing - therapeutic use | Adult | Anti-HIV Agents - therapeutic use | Antibodies, Neutralizing - adverse effects | Female | HIV Antibodies - therapeutic use | Historically Controlled Study | Antibodies, Monoclonal - immunology | Carrier State - immunology | HIV Infections - virology | Viremia - drug therapy | HIV Antibodies - administration & dosage | Carrier State - virology | HIV-1 - immunology | Viremia - virology | Antibodies, Monoclonal - administration & dosage | Viremia - prevention & control | Adolescent | Carrier State - drug therapy | HIV Infections - drug therapy | Viremia - immunology | Aged | HIV Envelope Protein gp160 - immunology | Infusions, Intravenous | Binding Sites, Antibody | Virus Activation - immunology | Virus Latency - immunology | Anti-HIV Agents - immunology | Drug Combinations | Physiological aspects | HIV patients | Care and treatment | Drug therapy, Combination | HIV antibodies | Antiretroviral drugs | Therapy | Antiviral agents | Interruption | Immunoglobulins | Viremia | Clinical trials | Viruses | Infections | Genomes | Antiretroviral therapy | Antiretroviral agents | Lymphocytes | Human immunodeficiency virus--HIV | Monoclonal antibodies | Reservoirs | Drug therapy | Bioinformatics | Binding sites | Index Medicus
Journal Article
Journal Article
PLoS ONE, ISSN 1932-6203, 12/2011, Volume 6, Issue 12, pp. e27864 - e27864
Objective: The primary objective was to assess the effect of MVC intensification on latently infected CD4(+) T cells in chronically HIV-1-infected patients... 
LOW-LEVEL VIREMIA | PLASMA VIREMIA | EXTENDED PERIODS | RESERVOIR | REPLICATION | IN-VIVO | BIOLOGY | IMMUNODEFICIENCY-VIRUS TYPE-1 | IMMUNE ACTIVATION | COMBINATION | RALTEGRAVIR INTENSIFICATION | Anti-HIV Agents - pharmacology | T-Lymphocyte Subsets - immunology | Cyclohexanes - pharmacology | Disease Reservoirs - virology | Humans | Middle Aged | Bacteria - drug effects | DNA, Circular - genetics | Male | Immunologic Memory - drug effects | T-Lymphocytes - virology | Cyclohexanes - therapeutic use | HIV Infections - immunology | Receptors, CCR5 - metabolism | T-Lymphocyte Subsets - drug effects | T-Lymphocytes - drug effects | Plasmids - genetics | Adult | Anti-HIV Agents - therapeutic use | Female | CCR5 Receptor Antagonists | Triazoles - therapeutic use | Bacteria - metabolism | HIV-1 - drug effects | HIV Infections - virology | Viremia - drug therapy | T-Lymphocyte Subsets - virology | Antiretroviral Therapy, Highly Active | Triazoles - pharmacology | HIV-1 - immunology | Viremia - virology | CD8-Positive T-Lymphocytes - virology | Lymphocyte Activation - drug effects | CD8-Positive T-Lymphocytes - drug effects | HIV Infections - drug therapy | T-Lymphocytes - immunology | Viremia - immunology | CD8-Positive T-Lymphocytes - immunology | Chronic Disease | Virus diseases | Highly active antiretroviral therapy | Antiviral agents | Care and treatment | Analysis | HIV patients | T cells | HIV (Viruses) | Health aspects | Therapy | Laboratories | Viremia | Change detection | Pathogenesis | CD8 antigen | Chronic infection | Clinical trials | Infections | Lymphocytes T | Lipopolysaccharides | Reduction | Cell activation | Lymphocytes | Antiretroviral agents | CD38 antigen | Human immunodeficiency virus--HIV | Bacteria | Drug therapy | Deoxyribonucleic acid--DNA | Translocation | Antiretroviral drugs | Immunological memory | CCR5 protein | Memory cells | Latent infection | T cell receptors | Patients | Antiretroviral therapy | CD4 antigen | Studies | Amplification | Infectious diseases | Reservoirs | Histocompatibility antigen HLA | Index Medicus | Deoxyribonucleic acid | HIV | DNA | Human immunodeficiency virus
Journal Article
JAIDS Journal of Acquired Immune Deficiency Syndromes, ISSN 1525-4135, 04/2019, Volume 80, Issue 4, pp. 423 - 428
Journal Article
Science, ISSN 0036-8075, 10/2016, Volume 354, Issue 6309, pp. 197 - 202
Journal Article
Proceedings of the National Academy of Sciences of the United States of America, ISSN 0027-8424, 5/2014, Volume 111, Issue 19, pp. 7078 - 7083
Journal Article
Journal of Acquired Immune Deficiency Syndromes, ISSN 1525-4135, 03/2012, Volume 59, Issue 3, pp. 229 - 235
Journal Article